AzTrials
AzTrials

Guided Bone RegenerationNCT06695338

Submerged Vs Non-Submerged Guided Bone Regeneration Simultaneous to Implant Placement.

A study testing Guided Bone Regeneration (Submerged) and Guided Bone Regeneration (Non-submerged) in people with Guided Bone Regeneration and Dental Implant, run by Universitat Internacional de Catalunya at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Dental implants are worldwide recognized one of the best manners to replace lost or hopeless prognosis teeth. There are different variables that creates proper conditions for long-term prognosis of implant treatments. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Guided Bone Regeneration (Submerged) and Guided Bone Regeneration (Non-submerged)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteSpain
Study dates
15 Dec 2024to 6 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Men and women over 18 years old.
  • Patients requiring single-unit implant restoration in any tooth site of the maxilla and mandible in between teeth.
  • Anticipation of a peri-implant buccal osseous dehiscence by means of a CT imaging (cone-beam computed tomography, CBCT) with a maximum vertical dimension height (VDH) of 50%.
  • Presence of adjacent teeth.
  • Presence of antagonist teeth.
  • Minimum primary stability of 25Ncm.
Show all 12Show fewer
  • Non-smokers or light smokers (< 10 cigarettes per day).
  • Absence of systemic diseases that could influence the outcome of the therapy (i.e., uncontrolled diabetes mellitus, osteoporosis, biphosphonate medication).
  • Tooth extraction performed at least 4 months before implant placement.
  • Good level of oral hygiene (Plaque Index < 25%) (Löe, 1967)
  • Written informed consent signed.
  • Keratinized mucosa of at least 2mm on the buccal and lingual of the implant.

Who cannot join

  • Implant surgery requiring sinus lift procedure.
  • Previous bone augmentation at the implant site.
  • Active periodontal disease.
  • Acute infection at the rehabilitation site.
  • Long-term non-steroidal anti-inflammatory drug therapy (3 months).
  • Lactating females or currently pregnancy.
  • Severe cognitive or psychiatric disorders.
  • Unwillingness to return for follow-up examination.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germán Pardo Perl, DDS, MSc contact

+34630083315

Germanpardo@uic.es

Spain1 site
  • Uic Barcelona

    Barcelona

    Germán Pardo Perl, +34 630083315, germanpardo@uic.es

Other trials in Spain

About this study

Dental implants are worldwide recognized one of the best manners to replace lost or hopeless prognosis teeth. There are different variables that creates proper conditions for long-term prognosis of implant treatments.

Implant position and surrounding bone around them, have been described in scientific literature to be key factors in the longevity of those treatments.

Read more

It has to be defined the \&amp;amp;#34;critical bone thickness\&amp;amp;#34; around implants. It basically means that implants has to be completely surrounded by bone, that will serve as protection. If the implants are not surrounded by bone, procedures as guided bone regeneration may be performed.

Those procedures can be executed before or simultaneously during the implant placement. In the standard procedure, the simultaneous guided bone regeneration during implant placement requires to leave the implant and the regeneration healing below the gingiva, needing a second surgery for accesing to those implants.

In this randomized controlled trial the hypothesis is to discover if not submerging this regenerations may show the same results than submerged ones.

For that, the objective is to study the different variables around these regeneration to evaluate the performance of non-submerged protocol.

Being tested
Guided Bone Regeneration (Submerged), Guided Bone Regeneration (Non-submerged)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guided Bone Regeneration (Submerged)Procedure or surgery

    Guided Bone Regeneration by means of bone xenograft and collagen membrane (submerged approach)

  • Guided Bone Regeneration (Non-submerged)Procedure or surgery

    Guided Bone Regeneration by means of bone xenograft and collagen membrane (Non submerged Approach)

Study groups in NCT06695338
Study groupRoleWhat they receive
Control Group (Submerged Approach)Active comparatorStandard/Conventional approach in which guided bone regeneration simultaneous to implant placement is leaved submerged under gingival tissue by suturing looking for first intention healing.
Receives: Procedure: Guided Bone Regeneration (Submerged)
Test Group (Non-Submerged Approach)ExperimentalTo test approach in which guided bone regeneration simultaneous to implant placement is leaved in a non-submerged manner with second intention healing around an abutment and interproximal suturing.
Receives: Procedure: Guided Bone Regeneration (Non-submerged)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vertical bone dimensional changes

    Comparison between CBCT images. Vertical bone changes in mm from initial CBCT to 12 months CBCT will be asessed.

    Measured: 0-12months

Secondary outcomes (6)
  1. Horizontal bone dimensional changes

    Comparison between CBCT images

    Measured: 0-12 months

  2. Buccal Bone thickness (Dehiscence resolution)

    Comparison between CBCT images

    Measured: 0-12 months

  3. Marginal Bone Loss (MBL)

    Comparison between 2d xrays

    Measured: 0-12 months

  4. Peri-implant clinical parameters

    Clinical variables

    Measured: 0-12 months

  5. Volumetric parameters

    Comparison between STL's models

    Measured: 0-12 months

  6. PROMs

    Patient Related Outcomes. (Overall satisfaction from 1-10, Pain perceived from 1-10, Willingness to repeat in case of need from 1-10)

    Measured: 0-12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2024
  2. Study start15 Dec 2024 (estimated)
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion6 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06695338
Sponsor's protocol ID
PER-ECL-2021-10
Status last verified
Nov 2024
First submitted
29 Sep 2024
Last updated
19 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Guided Bone Regeneration (Submerged) and Guided Bone Regeneration (Non-submerged) in people with Guided Bone Regeneration and Dental Implant, run by Universitat Internacional de Catalunya at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Germán Pardo Perl, DDS, MSc (+34630083315, Germanpardo@uic.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vertical bone dimensional changes (time frame: 0-12months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in